These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29642282)

  • 1. Effect of the S-nitrosoglutathione reductase inhibitor N6022 on bronchial hyperreactivity in asthma.
    Que LG; Yang Z; Lugogo NL; Katial RK; Shoemaker SA; Troha JM; Rodman DM; Tighe RM; Kraft M
    Immun Inflamm Dis; 2018 Jun; 6(2):322-331. PubMed ID: 29642282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
    Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ
    BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
    Blais CM; Davis BE; Cockcroft DW
    Respir Res; 2017 Aug; 18(1):146. PubMed ID: 28768531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance.
    Broeders ME; Molema J; Hop WC; Folgering HT
    Respir Med; 2005 Aug; 99(8):1046-52. PubMed ID: 15950147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo.
    Cheung D; van der Veen H; den Hartigh J; Dijkman JH; Sterk PJ
    J Appl Physiol (1985); 1994 Sep; 77(3):1325-32. PubMed ID: 7530706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
    Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP
    Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma.
    El-Gammal AI; Killian KJ; Scime TX; Beaudin S; Schlatman A; Cockcroft DW; Gauvreau GM
    Ann Am Thorac Soc; 2015 Jul; 12(7):1039-43. PubMed ID: 25871542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
    Colagiovanni DB; Drolet DW; Langlois-Forget E; Piché MP; Looker D; Rosenthal GJ
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):115-24. PubMed ID: 22210450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-airway obstruction, dynamic hyperinflation, and gas trapping despite normal airway sensitivity to methacholine in adults with chronic cough.
    Sood N; Turcotte SE; Wasilewski NV; Fisher T; Wall T; Fisher JT; Lougheed MD
    J Appl Physiol (1985); 2019 Feb; 126(2):294-304. PubMed ID: 30236044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma.
    Simard B; Turcotte H; Cockcroft DW; Davis BE; Boulay ME; Boulet LP
    Chest; 2005 Jan; 127(1):135-42. PubMed ID: 15653974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma.
    Anderson SD; Charlton B; Weiler JM; Nichols S; Spector SL; Pearlman DS;
    Respir Res; 2009 Jan; 10(1):4. PubMed ID: 19161635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma.
    Fujimura M; Sakamoto S; Kamio Y; Matsuda T
    Respir Med; 1993 Feb; 87(2):133-8. PubMed ID: 8497683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of candesartan, a type 1 angiotensin II receptor antagonist, on bronchial hyper-responsiveness to methacholine in patients with bronchial asthma.
    Myou S; Fujimura M; Kamio Y; Kita T; Watanabe K; Ishiura Y; Hashimoto T; Nakao S
    Br J Clin Pharmacol; 2002 Dec; 54(6):622-6. PubMed ID: 12492610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
    Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Stout AM; Mutka SC; Richards JP; Rosenthal GJ
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2338-42. PubMed ID: 22342142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway calibre as a confounder in interpreting bronchial responsiveness in asthma.
    Dirksen A; Madsen F; Engel T; Frølund L; Heinig JH; Mosbech H
    Thorax; 1992 Sep; 47(9):702-6. PubMed ID: 1359666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma.
    Hozawa S; Haruta Y; Ishioka S; Yamakido M
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1198-202. PubMed ID: 7551370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.